Acrux Ltd
Company Profile
Business description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Contact
103-113 Stanley Street
West Melbourne
MelbourneVIC3003
AUST: +61 383790100
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
36
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,006.80 | 116.00 | 1.30% |
CAC 40 | 7,822.67 | 0.67 | 0.01% |
DAX 40 | 24,289.51 | 81.42 | -0.33% |
Dow JONES (US) | 44,342.19 | 142.30 | -0.32% |
FTSE 100 | 8,992.12 | 19.48 | 0.22% |
HKSE | 24,825.66 | 326.71 | 1.33% |
NASDAQ | 20,895.65 | 10.01 | 0.05% |
Nikkei 225 | 39,819.11 | 82.08 | -0.21% |
NZX 50 Index | 12,880.40 | 25.01 | -0.19% |
S&P 500 | 6,296.79 | 0.57 | -0.01% |
S&P/ASX 200 | 8,757.20 | 118.20 | 1.37% |
SSE Composite Index | 3,534.48 | 17.66 | 0.50% |